Quick answers
- What is Abilify?
- Abilify is a brand name of Aripiprazole, a prescription medicine. The FDA NDC Directory lists 6 Abilify products in 6 strengths and forms.
- Who makes Abilify?
- Otsuka holds the FDA application for Abilify (NDA021436, approved November 15, 2002).
- Is there a generic or store brand of Abilify?
- Yes. The FDA NDC Directory lists 233 other products with the same active ingredients, strength and form as a Abilify product, 233 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Abilify?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 6 Abilify strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Abilify been recalled?
- FDA enforcement reports list 5 recalls of Abilify products; the newest started April 9, 2024. A recall usually concerns specific lots, not every product.
What Abilify is
Each Abilify product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Aripiprazole · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| aripiprazole 10 mg tablet (oral) | Abilify | 45 products, 31 companies | DailyMed |
| aripiprazole 15 mg tablet (oral) | Abilify | 36 products, 26 companies | DailyMed |
| aripiprazole 2 mg tablet (oral) | Abilify | 43 products, 30 companies | DailyMed |
| aripiprazole 20 mg tablet (oral) | Abilify | 37 products, 27 companies | DailyMed |
| aripiprazole 30 mg tablet (oral) | Abilify | 27 products, 22 companies | DailyMed |
| aripiprazole 5 mg tablet (oral) | Abilify | 45 products, 32 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Aripiprazole →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021436 | Otsuka | November 15, 2002 | 6 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| aripiprazole 10 mg tablet | Brand: Abilify | $18.62 per tablet Generic of the same strength and form: $0.1186–$2.42 per tablet |
| aripiprazole 15 mg tablet | Brand: Abilify | $18.65 per tablet Generic of the same strength and form: $0.1338–$1.81 per tablet |
| aripiprazole 2 mg tablet | Brand: Abilify | $18.67 per tablet Generic of the same strength and form: $0.1206 per tablet |
| aripiprazole 20 mg tablet | Brand: Abilify | $26.25 per tablet Generic of the same strength and form: $0.1818 per tablet |
| aripiprazole 30 mg tablet | Brand: Abilify | $26.23 per tablet Generic of the same strength and form: $0.1828 per tablet |
| aripiprazole 5 mg tablet | Brand: Abilify | $18.68 per tablet Generic of the same strength and form: $0.1165 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Abilify
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Abilify products.
- Otsuka America Pharmaceutical, Inc.6 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
April 9, 2024 · Class III · Ongoing · D-0466-2024
Cross Contamination with Other Products
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13 — Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
-
April 9, 2024 · Class III · Ongoing · D-0468-2024
Cross Contamination with Other Products
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13 — Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
-
April 9, 2024 · Class III · Ongoing · D-0467-2024
Cross Contamination with Other Products
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc. — Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
-
April 9, 2024 · Class III · Ongoing · D-0469-2024
Cross Contamination with Other Products
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13 — Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
-
November 2, 2012 · Class II · Terminated · D-181-2013
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35 — Bristol Myers Squibb Manufacturing Company
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.